Order

Size
Price
Stock
Qty

LY-3214996

 - Temuterkib
Axon 3893
CAS:  1951483-29-6
Purity:  99%
  • Soluble in DMSO
  • MF:  C22H27N7O2S
  • MW:  453.56

Description

LY-3214996 is an orally bioavailable, potent and highly selective inhibitor of ERK1 and ERK2, with IC50 of 5 nM for both enzymes in biochemical assays. It potently inhibits cellular phospho-RSK1 in BRAF and RAS mutant cancer cell lines. In an unbiased tumor cell panel sensitivity profiling for inhibition of cell proliferation, tumor cells with MAPK pathway alterations including BRAF, NRAS or KRAS mutation are generally sensitivity to LY-3214996. In tumor xenograft models, LY-3214996 inhibits PD biomarker phospho-p90RSK1 in tumors and the PD effects are correlated with compound exposures and anti-tumor activities.

More Information

Parent CAS No. 1951483-29-6
Chemical Name 6,6-Dimethyl-2-(2-(1-methyl-1H-pyrazol-5-ylamino)pyrimidin-4-yl)-5-(2-morpholinoethyl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-4-one
extra_info Sold in collaboration with Chemietek
SMILES N1C=CC(C2=CC3C(=O)N(CCN4CCOCC4)C(C)(C)C=3S2)=NC=1NC1=CC=NN1C
MFCD N.A.
InChi InChI=1S/C22H27N7O2S/c1-22(2)19-15(20(30)29(22)9-8-28-10-12-31-13-11-28)14-17(32-19)16-4-6-23-21(25-16)26-18-5-7-24-27(18)3/h4-7,14H,8-13H2,1-3H3,(H,23,25,26)
InChiKey JNPRPMBJODOFEC-UHFFFAOYSA-N
CID 121408882
Short Description ERK1 and ERK2 inhibitor

Related Products

AXON ID NAME FROM PRICE
1694 FR 180204

From $104.50

3741 GDC-0994

From $176.00

3803 SCH900353

From Inquiry

3836 VX-11e

From Inquiry

3867 SCH772984 hydrochloride

From Inquiry

4151 Ulixertinib hydrochloride

From Inquiry

4284 EI-52

From $154.00

Loading...